Characteristic patterns of N Oct-3 binding to a set of neuronal promoters

Journal of Molecular Biology

Volumn 339, Issue 5, 2004, Pages 1049-1058

  Blaud, Magali ^a   Vossen, Christine ^a   Joseph, Gérard ^a   Alazard, Robert ^a   Erard, Monique ^a   Nieto, Laurence ^a  

^a CNRS   (France)

Author keywords

DBD, DNA binding domain; h, homeodomain; HNF 3 ; HNF 3 , hepatocyte nuclear factor 3 ; N Oct 3; neuronal promoters; POU; s, specific

Indexed keywords

DNA; HEPATOCYTE NUCLEAR FACTOR 3; MONOMER; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR POU; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; FOXA2 PROTEIN, HUMAN; HCFC1 PROTEIN, HUMAN; HEPATOCYTE NUCLEAR FACTOR 3BETA; HOST CELL FACTOR C1; NUCLEAR PROTEIN; OCTAMER TRANSCRIPTION FACTOR 1; POU2F1 PROTEIN, HUMAN; POU5F1 PROTEIN, HUMAN;

ARTICLE; BRAIN TUMOR; CARCINOGENESIS; CORRELATION ANALYSIS; DATA ANALYSIS; DIMERIZATION; GENE TARGETING; NERVE CELL; NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TARGETING; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CIRCULAR DICHROISM; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROMOTER REGION; PROTEIN SECONDARY STRUCTURE; SEQUENCE ALIGNMENT;

STAPHYLOCOCCUS PHAGE 3A;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CIRCULAR DICHROISM; DIMERIZATION; DNA-BINDING PROTEINS; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HOST CELL FACTOR C1; HUMANS; MOLECULAR SEQUENCE DATA; NEURONS; NUCLEAR PROTEINS; OCTAMER TRANSCRIPTION FACTOR-1; OCTAMER TRANSCRIPTION FACTOR-3; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN SUBUNITS; SEQUENCE ALIGNMENT; TRANSCRIPTION FACTORS;

EID: 3042577558     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2004.04.035     Document Type: Article

References (30)

1. Phillips K, Luisi B. The virtuoso of versatility: POU proteins that flex to fit. J. Mol. Biol. 302:2000;1023-1039
2. Andersen B, Rosenfeld M.G. POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. Endocr. Rev. 22:2001;2-35
3. Scully K.M, Jacobson E.M, Jepsen K, Lunyak V, Viadiu H, Carriere C, et al. Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science. 290:2000;1127-1131
4. Remenyi A, Tomilin A, Pohl E, Lins K, Philippsen A, Reinbold R, et al. Differential dimer activities of the transcription factor Oct-1 by DNA- induced interface swapping. Mol. Cell. 8:2001;569-580
5. Klemm J.D, Rould M.A, Aurora R, Herr W, Pabo C.O. Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell. 77:1994;21-32
6. Kemler I, Schreiber E, Muller M.M, Matthias P, Schaffner W. Octamer transcription factors bind to two different sequence motifs of the immunoglobulin heavy chain promoter. EMBO J. 8:1989;2001-2008
7. Tomilin A, Remenyi A, Lins K, Bak H, Leidel S, Vriend G, et al. Synergism with the coactivator OBF-1 (OCA-B, BOB-1) is mediated by a specific POU dimer configuration. Cell. 103:2000;853-864
8. Schreiber E, Harshman K, Kemler I, Malipiero U, Schaffner W, Fontana A. Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins. Nucl. Acids Res. 18:1990;5495-5503
9. Schreiber E, Merchant R.E, Wiestler O.D, Fontana A. Primary brain tumors differ in their expression of octamer deoxyribonucleic acid-binding transcription factors from long-term cultured glioma cell lines. Neurosurgery. 34:1994;129-135
10. Eisen T, Easty D.J, Bennett D.C, Goding C.R. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression. Oncogene. 11:1995;2157-2164
11. Nakai S, Kawano H, Yudate T, Nishi M, Kuno J, Nagata A, et al. The POU domain transcription factor Brn-2 is required for the determination of specific neuronal lineages in the hypothalamus of the mouse. Genes Dev. 9:1995;3109-3121
12. Raynal J.F, Dugast C, Le Van Thai A, Weber M.J. Winged helix hepatocyte nuclear factor 3 and POU-domain protein brn-2/N- oct-3 bind overlapping sites on the neuronal promoter of human aromatic L-amino acid decarboxylase gene. Brain Res. Mol. Brain Res. 56:1998;227-237
13. Ang S.L, Rossant J. HNF-3 beta is essential for node and notochord formation in mouse development. Cell. 78:1994;561-574
14. Clark K.L, Halay E.D, Lai E, Burley S.K. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature. 364:1993;412-420
15. Millevoi S, Thion L, Joseph G, Vossen C, Ghisolfi-Nieto L, Erard M. Atypical binding of the neuronal POU protein N-Oct3 to noncanonical DNA targets. Implications for heterodimerization with HNF-3 beta. Eur. J. Biochem. 268:2001;781-791
16. Skala H, Porteu A, Thomas M, Szajnert M.F, Okazawa H, Kahn A, Phan-Dinh-Tuy F. Upstream elements involved in vivo in activation of the brain-specific rat aldolase C gene. Role of binding sites for POU and winged helix proteins. J. Biol. Chem. 273:1998;31806-31814
17. Li P, He X, Gerrero M.R, Mok M, Aggarwal A, Rosenfeld M.G. Spacing and orientation of bipartite DNA-binding motifs as potential functional determinants for POU domain factors. Genes Dev. 7:1993;2483-2496
18. Ballard D.W, Bothwell A. Mutational analysis of the immunoglobulin heavy chain promoter region. Proc. Natl Acad. Sci. USA. 83:1986;9626-9630
19. Jacobson E.M, Li P, Leon-del-Rio A, Rosenfeld M.G, Aggarwal A.K. Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility. Genes Dev. 11:1997;198-212
20. Rhee J.M, Gruber C.A, Brodie T.B, Trieu M, Turner E.E. Highly cooperative homodimerization is a conserved property of neural POU proteins. J. Biol. Chem. 273:1998;34196-34205
21. Costa R.H, Grayson D.R, Darnell J.E Jr. Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and alpha 1-antitrypsin genes. Mol. Cell. Biol. 9:1989;1415-1425
22. Shimizu S, Miyamoto Y, Hayashi M. Cell-type dependency of two Foxa/HNF3 sites in the regulation of vitronectin promoter activity. Biochim. Biophys. Acta. 1574:2002;337-344
23. Ramkumar T, Adler S. A requirement for the POU transcription factor, Brn-2, in corticotropin- releasing hormone expression in a neuronal cell line. Mol. Endocrinol. 13:1999;1237-1248
24. Thomson J.A, Murphy K, Baker E, Sutherland G.R, Parsons P.G, Sturm R.A, Thomson F. The brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells. Oncogene. 11:1995;691-700
25. Auchus R.J, Mastorakos G, Friedman T.C, Chrousos G.P. Corticotropin-releasing hormone production by a small cell carcinoma in a patient with ACTH-dependent Cushing's syndrome. J. Endocrinol. Invest. 17:1994;447-452
26. Vachtenheim J, Novotna H. Expression of the aromatic L-amino acid decarboxylase mRNA in human tumour cell lines of neuroendocrine and neuroectodermal origin. Eur. J. Cancer. 33:1997;2411-2417
27. Tsuchihashi T, Yamaguchi K, Abe K, Yanaihara N, Saito S. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors. Jpn J. Clin. Oncol. 22:1992;232-237
28. Gregory R.J, Cahill P.B, Thurlow D.L, Zimmermann R.A. Interaction of Escherichia coli ribosomal protein S8 with its binding sites in ribosomal RNA and messenger RNA. J. Mol. Biol. 204:1988;295-307
29. Overdier D.G, Porcella A, Costa R.H. The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix. Mol. Cell. Biol. 14:1994;2755-2766
30. Combet C, Blanchet C, Geourjon C, Deleage G. NPS[commat]: network protein sequence analysis. Trends Biochem. Sci. 25:2000;147-150